Also, as a noninvasive test, blood sample testing has the advantages of easy detection, low cost, high patient acceptance, and facilitates the early detection and follow-up management of cancer.[12–17] A study constructed a unique prognostic model using indicators from blood sample testing (hemoglobin, platelets, albumin, C-reactive protein [CRP], and lactate dehydrogenase [LDH]) called the LabBM score. Here, CRP is linked to cancer.